Today’s pharmaceutical industry faces a challenge: traditional manufacturing was not designed to meet current demand for patient-appropriate dosage forms, flexible dosing, and real-world usability. At the same time, evolving regulatory expectations from the FDA and EMA are raising the bar for how drug products perform outside controlled clinical settings.
This webinar explores how pharmaceutical 3D printing can help solve these challenges by enabling a shift from standardized production to adaptable, patient-focused dosage design. Experts will discuss unmet patient needs in populations such as pediatrics, emerging regulatory frameworks, and how advanced manufacturing platforms can support personalized therapies, flexible dosing, and improved treatment experiences.
3DP is transforming manufacturing from a process step into a strategic differentiator for pharmaceutical companies. Attendees will gain actionable insight into how they can enhance product value, patient outcomes and market competitiveness.
In this webinar you'll learn:
Please check the highlighted fields and try again.
Please enter your mailing address.